NKGen raises $2M via stock and warrant sale; OTC moves shares to Expert Market

NKGen Biotech, Inc.

Sold 8M shares at $0.25/share and 8M warrants to Japanese investor HekaBio K.K., raising $2M.
OTC Markets Group moves NKGN to Expert Market on July 17 due to delinquent SEC filings.
Funds to help regain filing compliance; company plans uplist to OTCQB, then Nasdaq or NYSE American.
Expected to close acquisition of majority stake in NKMax out of bankruptcy in coming month.
CEO cites strategic investor as key to bringing troculeucel to the Japanese market.

item 1.01item 3.02item 7.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.